Toll-like receptor 7, Toll-like receptor 8, and Toll-like receptor 9 (TLR7/8/9)

Toll-like receptors 7, 8, and 9 (TLR7/8/9) are a group of endosomal pattern recognition receptors that play a critical role in the innate immune system by sensing nucleic acids (Adv Exp Med Biol. 2024, 1444, 97-108). TLR7 and TLR8 are specialized for detecting single-stranded RNA, while TLR9 recognizes unmethylated CpG DNA motifs, which are characteristic of viral and bacterial pathogens (J. Immunother. Cancer, 2025). Upon ligand binding, these receptors recruit the adapter protein MyD88, initiating a signaling cascade that leads to the production of type I interferons and pro-inflammatory cytokines such as TNF-alpha and IL-6 (Premier Science, 2024). This pathway is essential for anti-viral and anti-tumor immunity but can become pathologically activated by self-nucleic acids in autoimmune conditions. Specifically, overactivation of the TLR7/8/9 pathway is a central driver of systemic lupus erythematosus (SLE) and other interferon-mediated diseases (ACS Med. Chem. Lett. 2020, 11, 9, 1751–1758). Consequently, small-molecule antagonists are being developed to treat these autoimmune disorders by blocking aberrant signaling. Conversely, TLR7/8/9 agonists are utilized as vaccine adjuvants and in cancer immunotherapy to stimulate robust, Th1-biased immune responses.

Other names

Endosomal Toll-like receptorsNucleic acid-sensing TLRsTLR7/8/9 pathwayEndosomal TLR pathway

Antagonism of endosomal nucleic acid sensing to inhibit MyD88-dependent signaling and reduce interferon/cytokine production; Agonism of endosomal receptors to induce Th1-biased immune responses and interferon-alpha production.